RETHYMIC
Total Payments
$1.9M
Transactions
320
Doctors
57
Companies
2
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $1.6M | 100 | 8 |
| 2023 | $244,674 | 212 | 50 |
| 2022 | $82,118 | 8 | 3 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.5M | 85 | 80.7% |
| Consulting Fee | $205,681 | 28 | 10.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $67,701 | 13 | 3.6% |
| Grant | $50,000 | 1 | 2.6% |
| Travel and Lodging | $33,739 | 78 | 1.8% |
| Food and Beverage | $9,533 | 115 | 0.5% |
Payments by Type
Research
$1.5M
85 transactions
General
$366,653
235 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| STUDY OF COLLECTION AND TRANSFERENCE OF THYMUS TISSUE | Sumitomo Pharma America, Inc. | $553,109 | 0 |
| PROTOCOL DEV-2022-001-P: STUDY OF COLLECTION AND TRANSFERENCE OF THYMUS TISSUE | Sumitomo Pharma America, Inc. | $306,379 | 0 |
| Congenital Athymia Patient Registry | Sumitomo Pharma America, Inc. | $269,563 | 1 |
| Research 6 Natural History | Sumitomo Pharma America, Inc. | $240,660 | 0 |
| Open-label observational trial to evaluate long-term activity and safety Opinion of the Paediatric Committee on the agreement of a Paediatric Investigation of allogeneic cultured postnatal thymus-derived tissue in children from birth to less than 18 years of age with congenital athymia. | Sumitomo Pharma America, Inc. | $163,010 | 0 |
Top Doctors Receiving Payments for RETHYMIC — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hospitalist | Wilmington, NC | $109.61 | 1 |
| , M.D | Internal Medicine | Detroit, MI | $101.34 | 1 |
| , M.D | Internal Medicine | Detroit, MI | $101.33 | 1 |
| , MD | Psychiatry | Manassas, VA | $101.33 | 1 |
| , DNP, APRN, FNP-C | Registered Nurse | Fort Worth, TX | $50.00 | 1 |
| , MD | Pediatrics | Saint Louis, MO | $50.00 | 1 |
| , MD | Allergy & Immunology | Hershey, PA | $50.00 | 1 |
| , DO/MBA | Pediatric Allergy/Immunology | Kansas City, MO | $50.00 | 1 |
| Brenda Snyder | Pediatrics | Kansas City, MO | $50.00 | 1 |
| , M.D | Pediatric Allergy/Immunology | Aurora, CO | $50.00 | 1 |
| , MD | Internal Medicine | Chicago, IL | $50.00 | 1 |
| , D.O | Pediatric Allergy/Immunology | Baltimore, MD | $50.00 | 1 |
| , CPNP | Pediatrics | Baltimore, MD | $50.00 | 1 |
| , M.D | Pediatric Allergy/Immunology | Baltimore, MD | $50.00 | 1 |
| , MD, MS | Pediatric Allergy/Immunology | Durham, NC | $50.00 | 1 |
| , M.D | Pediatrics | Milwaukee, WI | $50.00 | 1 |
| , MEDICAL STUDENT | Allergy & Immunology | Durham, NC | $50.00 | 1 |
| , MD | Pediatric Pulmonology | Crest Hill, IL | $50.00 | 1 |
| , M.D | Pediatric Allergy/Immunology | Winston Salem, NC | $50.00 | 1 |
| , MD | Pediatric Rheumatology | Milwaukee, WI | $50.00 | 1 |
| , M.D | Infectious Disease | Bethesda, MD | $50.00 | 1 |
| , MD | Allergy & Immunology | New Orleans, LA | $50.00 | 1 |
| , M.D | Allergy & Immunology | Grand Rapids, MI | $50.00 | 1 |
| , MD | Pediatric Allergy/Immunology | Miami, FL | $50.00 | 1 |
| , PNP | Pediatrics | Saint Louis, MO | $50.00 | 1 |
Ad
Manufacturing Companies
- Sumitomo Pharma America, Inc. $1.8M
- Enzyvant Therapeutics, Inc. $82,118
Product Information
- Type Drug
- Total Payments $1.9M
- Total Doctors 57
- Transactions 320
About RETHYMIC
RETHYMIC is a drug associated with $1.9M in payments to 57 healthcare providers, recorded across 320 transactions in the CMS Open Payments database. The primary manufacturer is Sumitomo Pharma America, Inc..
Payment data is available from 2022 to 2024. In 2024, $1.6M was paid across 100 transactions to 8 doctors.
The most common payment nature for RETHYMIC is "Unspecified" ($1.5M, 80.7% of total).
RETHYMIC is associated with 5 research studies, including "STUDY OF COLLECTION AND TRANSFERENCE OF THYMUS TISSUE" ($553,109).